Kestra Medical Technologies, Ltd. (KMTS) EBITDA
- 2026-07-31: Basis Reported; EBITDA -$34.99M*; Operating income -$37.66M; Depreciation and amortization $2.66M.
- 2026-04-30: Basis Reported; EBITDA -$37.02M; Operating income (m); Depreciation and amortization (m).
- 2026-01-31: Basis Reported; EBITDA -$32.78M*; Operating income -$34.77M; Depreciation and amortization $1.98M*.
- 2025-10-31: Basis Reported; EBITDA -$29.38M*; Operating income -$31.75M; Depreciation and amortization $2.37M*.
Complete source-backed ebitda history.
- Available history
- 2024-04-30 to 2026-04-30
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-07-31 | Reported | -$34.99M* | -$37.66M | $2.66M | $30.97M | -112.99%* | $8.34M | -$32.30M | $13.47M | $6.80M | $48.36M | $50.00K |
|---|
| 2026-04-30 | Reported | -$37.02M | (m) | (m) | (m) | -129.27% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2026-01-31 | Reported | -$32.78M* | -$34.77M | $1.98M* | $24.55M | -133.52%* | $9.80M* | -$18.37M* | $11.65M | $4.97M | $42.70M | $35.00K |
|---|
| 2025-10-31 | Reported | -$29.38M* | -$31.75M | $2.37M* | $22.57M | -130.21%* | $7.26M* | -$18.34M* | $11.14M | $4.88M | $38.30M | $34.00K |
|---|
| 2025-07-31 | Reported | -$26.85M | (m) | (m) | (m) | -138.61% | $8.17M | -$26.27M | $10.52M | $4.00M | $33.73M | $33.00K |
|---|
| 2025-04-30 | Reported | -$46.38M | (m) | (m) | (m) | -269.11% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-01-31 | Reported | -$18.71M* | -$20.60M | $1.89M* | $15.09M | -124.01%* | $4.06M* | -$18.00M* | $8.54M | $3.35M | $23.80M | $18.00K |
|---|
| 2024-10-31 | Reported | -$17.27M* | -$19.13M | $1.87M* | $14.71M | -117.37%* | $4.45M* | -$18.06M* | $8.88M | $3.51M | $21.45M | $8.00K |
|---|
| 2024-07-31 | Reported | -$16.06M | (m) | (m) | (m) | -125.61% | $7.04M | -$17.50M | $8.58M | $3.40M | $19.23M | $7.00K |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-04-30 | Reported | -$126.03M | (m) | (m) | (m) | -132.49% | $34.89M | -$81.70M | $46.26M | $19.48M | $164.12M | $294.00K |
|---|
| 2025-04-30 | Reported | -$98.41M | (m) | (m) | (m) | -164.52% | $22.94M | -$77.61M | $35.60M | $15.65M | $114.94M | $135.00K |
|---|
| 2024-04-30 | Reported | -$73.5M | (m) | (m) | (m) | -264.27% | $12.23M | -$72.23M | $27.45M | $15.49M | $69.94M | $24.00K |
|---|